Table 3.
Model | MSC Origin | Labeling Method | Administration Route | Maximum Follow up | Detection in Tumor | Publication |
---|---|---|---|---|---|---|
NB xenograft model in NOD/SCID mice | human, BM | Radiolabeling | IP | 48 h | Yes | Cussó et al. [126] |
TH-MYCN transgenic mouse | human, AT | Near-IR | IP, IV | 24 h | Only i.p. | Kimura et al. [127] |
TH-MYCN transgenic mouse | mouse, BM | GFP | IP | 2 weeks | Yes | Maniwa et al. [57] |
IP–intraperitoneally; IV–intravenously, AT–adipose tissue, BM–bone marrow.